MedPath

Non-contrast 3D MR Angiography for Assessment of the Thoracic Aorta in Pregnancy

Completed
Conditions
Magnetic Resonance Imaging
Pregnancy
Registration Number
NCT02793570
Lead Sponsor
University Hospital Birmingham NHS Foundation Trust
Brief Summary

Introduction: Native magnetic resonance angiography (MRA) is recommended to assess the thoracic aorta during pregnancy, avoiding the risks of ionising radiation and contrast agent administration. This guidance is however, based only on consensus opinion supported by limited case reports (level of evidence C).

Aim: To evaluate the feasibility of performing native 3D steady-state free-precession (SSFP) MRA in pregnant subjects with inherited aortopathy to guide timing and mode of delivery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
15
Inclusion Criteria
  • Any pregnant subject with a history of familial aortopathy
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gestation at delivery40 weeks
Completion of non-contrast 3D MRA aorta40 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

QEHB

🇬🇧

Birmingham, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath